SCHEMBL30467459

SCHEMBL30467459

CCCCOC(=O)N1CC2(CC(C(C)=O)C2)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.41
▸ GBA2 Q9HCG7 1/20 0.37
▸ HRH2 P25021 1/20 0.36
▸ HRH1 P35367 1/20 0.36
▸ ATM Q13315 1/20 0.35
▸ TSHR P16473 3/20 0.35
▸ NAAA Q02083 1/20 0.34
▸ EPHX2 P34913 3/20 0.34
▸ HPGD P15428 1/20 0.33
▸ BCHE P06276 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ EPHX1 P07099 1/20 0.33
▸ CHRM2 P08172 1/20 0.32
▸ CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23859720 0.85 LMNA (0.49) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30013395 0.84 LMNA (0.48) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30711487 0.81 SMN1; SMN2 (0.51) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL18639389 0.81 LMNA (0.46) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30177247 0.80 LMNA (0.44) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL31282074 0.80 LMNA (0.44) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL5158334 0.80 LMNA (0.53) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL30063495 0.79 LMNA (0.43) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL31365786 0.78 LMNA (0.43) LMNAPOLBSMN1; SMN2ALDH1A1GBA2
SCHEMBL21358300 0.78 SMN1; SMN2 (0.43) LMNAPOLBSMN1; SMN2ALDH1A1GBA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023130050-A1 MONOACYLGLYCEROL LIPASE INHIBITORS AND USE THEREOF FOR THE TREATMENT AND MANAGEMENT OF PAIN PSY THERAPEUTICS, INC. (US) 2023-07-06 — — WO disclosed
Send feedback